Palvella Therapeutics's top three insider shareholders as of June 18, 2026 are George M Jenkins (Director, 187.62K shares), Capital Management, Llc Adar1 (TenPercentOwner, 144.64K shares), Elaine J Heron (Director, 47.81K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Partners L P/Il Bvf | - | 38,961 | 0 | 17 Dec, 2024 |
| Elaine J Heron | - | 47,812 | 0 | 02 Mar, 2026 |
| Christopher P Kiritsy | - | 20,000 | 0 | 30 May, 2023 |
| George M Jenkins | - | 187,616 | 0 | 01 Apr, 2026 |
| Tim Demuth | Chief Medical Officer | 6,000 | 0 | 16 May, 2022 |
| Shane Olwill | Chief Development Officer | 4,638 | 0 | 01 Sep, 2021 |
| Capital Management, Llc Adar1 | - | 0 | 144,641 | 12 Aug, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 15 Apr, 2026 | Kathleen Goin | Common Stock | A | 2,154 | $7.14 | 2,154 | D | M |
| 15 Apr, 2026 | Kathleen Goin | Common Stock | A | 2,148 | $9.08 | 4,302 | D | M |
| 15 Apr, 2026 | Kathleen Goin | Common Stock | D | 1,502 | $125.96 | 2,800 | D | S |
| 15 Apr, 2026 | Kathleen Goin | Common Stock | D | 1,500 | $127.13 | 1,300 | D | S |
| 15 Apr, 2026 | Kathleen Goin | Common Stock | D | 561 | $128.23 | 739 | D | S |
| 15 Apr, 2026 | Kathleen Goin | Common Stock | D | 639 | $129.17 | 100 | D | S |
| 15 Apr, 2026 | Kathleen Goin | Common Stock | D | 100 | $130.33 | 0 | D | S |
| 15 Apr, 2026 | Kathleen Goin | Stock Option (Right to Buy) | D | 2,154 | $0.00 | 12,935 | D | M |
| 15 Apr, 2026 | Kathleen Goin | Stock Option (Right to Buy) | D | 2,148 | $0.00 | 12,888 | D | M |
| 13 Apr, 2026 | John Doux | Stock Option (Right to Buy) | A | 6,000 | $0.00 | 6,000 | D | A |
| 13 Apr, 2026 | John Doux | Stock Option (Right to Buy) | A | 6,000 | $0.00 | 6,000 | D | A |
| 13 Apr, 2026 | John Doux | Stock Option (Right to Buy) | A | 6,000 | $0.00 | 6,000 | D | A |
| 30 Mar, 2026 | George M Jenkins | Common Stock | A | 445 | $112.30 | 187,616 | D | P |
| 18 Mar, 2026 | Kathleen Goin | Common Stock | A | 2,154 | $7.14 | 2,154 | D | M |
| 18 Mar, 2026 | Kathleen Goin | Common Stock | A | 2,148 | $9.08 | 4,302 | D | M |
| 18 Mar, 2026 | Kathleen Goin | Common Stock | D | 2,268 | $117.56 | 2,034 | D | S |
| 18 Mar, 2026 | Kathleen Goin | Common Stock | D | 1,730 | $118.37 | 304 | D | S |
| 18 Mar, 2026 | Kathleen Goin | Common Stock | D | 304 | $119.08 | 0 | D | S |
| 18 Mar, 2026 | Kathleen Goin | Stock Option (Right to Buy) | D | 2,154 | $0.00 | 15,089 | D | M |
| 18 Mar, 2026 | Kathleen Goin | Stock Option (Right to Buy) | D | 2,148 | $0.00 | 15,036 | D | M |